News
Researchers identify the molecule that could be involved in the formation of bone metastases in prostate cancer
A group of researchers from IDIBELL, UB and Vall d’Hebrón Recerca have identified a molecule involved in bone metastasis associated with prostate cancer that could be useful in the design of new therapies for its treatment.
IDIBELL receives a € 3,000 donation for epilepsy research
On Wednesday 12th January, two representatives of the association “Si jo puc, tu també #epilep” (meaning “if I can, you can too”) handed over a € 3,000 check to IDIBELL and Bellvitge University Hospital to help fund their research on epilepsy. The event was attended by two researchers from the neuroscience program: Mercè Falip, principal […]
Starts the “Smoke-free Homes” project!
This project aims to adapt and test the effectiveness of an intervention targeted to families with children that adults smoke at home.
Improvement in the treatment of autoimmune aplastic anemia
The addition of Eltrombopag to conventional treatment with immunosuppressants increases the effectiveness and speed of treatment. The study, published in the New England Journal of Medicine, is a phase 3 clinical trial involving IDIBELL and ICO.
Molecular screening in advanced breast cancer patients allows for personalized therapeutic decisions
The scientific journal Frontiers in Oncology recently published the first results of the AGATA SOLTI-1301 pilot study, which aimed to assess how feasible is the implementation of molecular screening in a real-life environment and whether patients could benefit from a targeted treatment if a mutation is detected. This study involved 260 patients with advanced breast […]
A new genomic medicine strategy improves the diagnostic of leukodystrophies
With the new strategy, published in the journal Neurology, the percentage of diag-nosed cases has doubled, new diseases and their genetic cause have been dis-covered, and the described clinical pictures have been extended.
IDIBELL renews the accreditation “Excellence in Human Resources” of the European Commission
The Human Resources Strategy for Researchers (HRS4R) supports institutions and research centers in the implementation of human resources initiatives that promote the researchers’ attraction and the development of the research career.
The forerunner of IDIBELL Dr. Miquel Rutllant has died
On December 26, Dr. Miquel Rutllant left us. He was a key person in the creation of what we now know as IDIBELL and one of the forerunners of biomedical research in our country.
What are the genetic reasons behind resistance to COVID-19?
It is proven that SARS-CoV-2 infection manifests in very different ways: some cases simply show mild discomfort for a few days, others need to be admitted to the ICU and some others even go through it without experiencing any kind of symptom. There are also cases where a person, despite having been living with a […]